REFERENCES
- Ahrendt S.A., Decker P.A., Alawi E.A., Zhu Yr Y.R., et al.. (2001) Cancer, 92, 1525–1530.
- Al Zeyadi M (2008) Tissue Microarray Analysis of EGFR Copy Number Changes In Lung Cancer, MSc. Thesis, Sofia University, Bulgaria.
- Awaya H., Takeshima Y., Amatya V.J., Furonaka O., et al.. (2004) Pathol. Int., 54(7), 486–489.
- Barnes L.D., Garrison P.N., Siprashvili Z., Guranowski A., et al.. (1996) Biochemistry, 35, 11529–11535.
- Belinsky S.A., Nikula K.J., Palmisano W.A., Michels R., et al.. (1998) P. Natl. Acad. Sci. USA, 95, 11891–11896.
- Bennett W.P., Colby T.V., Travis W.D., Borkowski A., et al.. (1993) Cancer Res., 53, 4817–4822.
- Bergh J.C. (1990) Am. Rev. Respir. Dis., 142(6 Pt 2),S20–26.
- Berrieman H.K., Ashman J.N., Cowen ME., Greenman J., et al.. (2004) Brit. J. Cancer, 90, 900–905.
- Brabender J., Usadel H., Danenberg K.D., Metzger R., et al.. (2001) Oncogene, 20(27), 3528–3532.
- Brena R.M. (2007). Aberrant DNA, PhD Dissertation, Ohio State University, pp. 6–60.
- Breuer R.H., Postmus P.E., Smit E.F. (2005) Respiration,72(3), 313–330.
- Cairns P., Polascik T.J., Eby Y., et al.. (1995) Nat. Genet., 11, 210–212.
- Carretero J., Shimamura T., Rikova K., Jackson A.L., et al.. (2010) Cancer Cell, 17, 547–559.
- Cecil R.L., Goldman L., Ausiello D.A. (2007) Cecil Textbook of Medicine, 23rd Ed., W.B. Saunders Elsevier, Philadelphia.
- Chang P.M., Yeh Y.C., Chen T.C., Wu Y.C., et al.. (2013) Ann. Surg. Oncol., (in press).
- Cherneva R., Dimova I. (2006) Balk. J. Med. Gen., 9(1–2), 9–17.
- Chung G.T., Sundaresan V., Hasleton P., Rudd R., et al.. (1995) Oncogene, 11, 2591–2598.
- Cooper D.N. (2005) The Molecular Genetics of Lung Cancer, Springer, Berlin, Heidelberg, NY.
- Dammann R., Takahashi T., Pfeifer G.P. (2001) Oncogene, 20, 3563–3567.
- Demopoulos K., Arvanitis D.A., Vassilakis D.A., Siafakas N.M., Spandidos D.A. (2002) J. Cell Mol. Med., 6(2), 215–222.
- Denissenko M.F., Pao A., Pfeifer G.P., Tang M. (1998) Oncogene, 16(10), 1241–1249.
- Devereux T.R., Taylor J.A., Barrett J.C. (1996) chest, 109(3 Suppl.),14S–19S.
- Dooley A.L., Winslow M.M., Chiang D.Y., Banerji S., et al.. (2011) Gene. Dev., 25(14), 1470–1475.
- Dosaka-Akita H., Hu S.X., Fujino M., Harada M., et al.. (1997) cancer, 79, 1329–1337.
- Engelman J.A., Zejnullahu K., Mitsudomi T., Song Y., et al.. (2007) Science, 316, 1039–1043.
- Fong K.M., Sekido Y., Minna J.D. (1999) J. Thorac. Cardiov. Sur., 118(6), 1136–1152.
- Frame S., Balmain A. (2000) Curr Opin Genet Dev, 10, 106–113.
- Frederick L., Eley G., Wang X.Y., James C.D. (2000) Neuro-Oncology, 2, 159–163.
- Fröhling S., Döhner H. (2008) New Engl. J. Med., 359, 722–734.
- Gene Cards (2013) GPC5 TP53 gene <http://www.genecards.org/cgi-bin/carddisp.pl?gene=GPC5>
- Gilliland F.D., Harms H.J., Crowel R.E., Li Y.F., Willink R., Belinsky S.A. (2002) Cancer Res., 62(8), 2248–2252.
- Gschwind A., Fischer O.M., Ullric A. (2004) Nat. Rev. Cancer, 4, 361–370.
- Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L. et al.. (1999) nature, 400(6743), 464–468.
- Hibi K., Takahashi T., Yamakawa K., Ueda R., et al.. (1992) Oncogene,7, 445–449.
- Hirsch F.R., Varella-Garcia M., Bunn P.A. Jr., Di Maria M.V., et al.. (2003) J. Clin. Oncol., 21(20), 3798–3807.
- Hiyama K., Hiyama E., Ishioka S., Yamakido M., et al.. (1995) J. Natl. Cancer I., 87, 895–902.
- Hsu D.S., Acharya C.R., Balakumaran B.S., Riedel R. F., et al.. (2009) P. Natl. Acad. Sci. USA, 106(13), 5312–5317.
- Inoue K., Sugiyama T., Taneja P., Morgan R.L., Frazier D.P. (2008) Cancer Res., 68(12), 4487–4490.
- Jemal A., Bray F., Center M.M., Ferlay J., et al.. (2011) CA Cancer J. Clin., 61(2), 69–90.
- Kalomenidis I., Orphanidou D., Papamichalis G., Vassilakopoulos T., et al.. (2001) Lung, 179(5), 265–278.
- Kendall J., Liu Q., Bakleh A., Krasnitz A., et al.. (2007) P. Natl. Acad. Sci. USA, 104(42), 16663–16668.
- Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., et al.. (1994) Science, 266, 2011–2015.
- Knudson A.G. (2001) Nat. Rev. Cancer, 1, 157–162.
- Kok K., Osinga J., Carritt B., Davis MB., et al.. (1987) Nature, 330(6148), 578–581.
- Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.T., Giger R.J., Ginty D.D. (1997) Cell, 90, 753–762.
- Krystal G., Birrer M., Way J., Nau M., et al.. (1988) Mol. Cell Biol., 8, 3373–3381.
- Lamy A., Sesboue R., Bourgignon J., Datur B., et al.. (2002) Int. J. Cancer, 100(2), 189–193
- Lechner J.F., Fugaro J.M. (2000) In: Lung Cancer. Principles and Practice, 2nd Ed. (H.I. Pass, J.B. Mitchell, et al.. Eds.), Lippincott Williams & Williams, Philadelphia, 89–97.
- Lingfei K., Pingzhang Y., Zhengguo L., Jianhua G., Yaowu Z.A. (1998) cancer lett., 130, 93–101.
- Ma P.C., Kijima T., Maulik G., Fox E.A., et al.. (2003) Cancer Res., 63, 6272–6281.
- Mallakin A., Sugiyama T., Taneja P., Matise L.A., et al.. (2007) cancer cell, 12(4), 381–394.
- Marsit C.J., Zheng S., Aldape K., Hinds P.W., et al.. (2005) Hum Pathol., 36(7), 768–776.
- Matakidou A., Eisen T., Houlston R.S. (2005) Br. J. Cancer. 93(7), 825–833
- Merlo A., Herman J.G., Mao L., Lee D.J., et al.. (1995) Nat. Med., 1, 686–692.
- Mori N., Yokota J., Akiyama T., Sameshima Y. (1990) Oncogene, 5, 1713–1717.
- Morstyn G., Brown J., Novak U., Gardner J., et al.. (1987) Cancer Res., 47, 3322–3327.
- Murphy D.J., Junttila M.R., Pouyet L., Karnezis A., et al.. (2008) Cancer Cell, 14(6), 447–457.
- National Center for Biotechnology (2012) UniGene entry for cyclin-dependent kinase inhibitor 1A (p21, Cip1) http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?ORG=Hs&MAXEST=999999&CID=370771
- Pao W., Mller V.A. (2005) J. Clin. Oncol., 23(11), 2556–2568.
- Potiron V.A., Sharma G., Nasarre P., Clarhaut J.A. et al.. (2007) Cancer Res., 67, 8708–8715.
- Puisieux A., Lim S., Groopman J., Ozturk M. (1991) Cancer Res., 51, 6185–6189.
- Puisieux A., Valsesia-Wittmann S., Ansieau S. (2006), A twist for survival, Br J Cancer, 16;94(1):13–7.
- Richardson G.E., Johnson B.E. (1993) Semin. Oncol., 20, 105–127.
- Robles A.I., Linke S.P., Harris C.C. (2002) Oncogene, 21, 6898–6907.
- Roengvoraphoj M., Tsongalis G.J., Dragnev K.H., Rigas J.R. (2013) Cancer Treat. Rev., (in press).
- Rom W.N., Hay J.G., Lee T.C., Jiang Y., Tchou-Wong K.M. (2000). Molecular and genetic. Am. J. Resp.ir Crit Care Med, 161,:1355–1367.
- Rom W.N., Tchou-Wong K.-M (2003) Methods in Molecular Medicine, 75, 3–28.
- Rusin M.R., Okamoto A., Chorazy M., Czyzewski K. (1996) Int. J. Cancer, 65(6), 734–739.
- Schauer I.E., Siriwardana S., Langan T.A., Sclafani R.A. (1994) P. Natl. Acad. Sci. USA, 91, 7827–7831.
- Sekido Y., Bader S., Latif F., Gnarra J.R., et al.. (1994) Oncogene, 9, 1599–1604.
- Sen S. (2000) Curr. Opin. Oncol., 12(1), 82–88.
- Sequist L.V., Joshi V.A., Janne P.A., Muzikansky A., et al.. (2007) Oncologist, 12(1), 90–98.
- Shames D., Girard L., Gao B., Sato M., et al.. (2006) PLoS Med., 3(12),e486.
- Shapiro G.I., Park J.E., Edwards C.D., Mao L., et al.. (1995) Cancer Res., 55, 6200–6209.
- Sharpless N.E., DePinho R.A. (2002) Cell, 110, 9–12.
- Shepherd F.A., Bunn P.A., Paz-Ares L. (2013) Am Soc Clin Oncol Educ Book,339–46%.
- Sherr C.J. (2004) Cell, 116, 235–246.
- Shigematsu H., Lin L., Takahashi T., Nomura M., et al.. (2005) J. Natl. Cancer I., 97(5), 339–346.
- Sjalander A., Birgander R., Rannug A., Alexandrie A., et al.. (1996) Hum. Hered., 46, 221–225.
- Skaug V., Ryberg D., Kure E., Arab M., et al.. (2000) Clin. Cancer Res., 6(3), 1031–1037.
- Smith D.I., Huang H., and Wang L. (1998) Int. J. Oncol., 12, 187–196.
- Song L., Turkson J., Karras J.G., Jove R., Haura E.B. (2003) Oncogene, 22, 4150–4165.
- Sozzi G., Veronese M.L., Negrini M., Baffa R., et al.. (1996) Cell, 85, 17–26.
- Sumitomo K., Shimizu E., Shinohara A., Yokota J., Sone S. (1999) Int. J. Oncol.,14(6), 1075–1080.
- Swank P.R., Greenberg S.D., Hunter et al.. (1989) Diagn. Cytopathol, 5, 98–103.
- Tal M., Wetzler M., Josefberg Z., Gutman M., et al.. (1988) Cancer Res., 48, 1517–1520.
- Tomizawa Y., Kohno T., Kondo H., Otsuka A., et al.. (2002) Clin Cancer Res., 8, 2362–2368.
- Tong X., Li K., Luo Z., Lu B., et al.. (2009) Am. J. Pathol., 174(5), 1931–1939.
- Toyooka S., Toyooka K.O., Maruyama R., Virmani A., et al.. (2001) Mol. Cancer Ther., 1(1), 61–67.
- Tsai C.M., Levitzki A., Wu L.H., Chang K.T., et al.. (1996) Cancer Res., 56, 1068–1074.
- Vaissiere T., Hung R.J., Zaridze D., Moukeria A., et al.. (2009) Cancer Res., 69, 243–252.
- Vuillemenot B.R., Pulling L.C., Palmisano W.A., Hutt J.A., Belinsky S.A. (2004) Carcinogenesis, 25(4), 623–629.
- Wagner B.J., Presnell S.P. (2009) In: Basic Concepts of Molecular Biology (T.C. Allen, P.T. Cagle, Eds.), Springer, Dodrecht, 97–108.
- Wang M. (2003) Fine Mapping and Candidate Gene Analyses of Murine Lung Tumor Susceptibility Genes, PhD Dissertation, Ohio State University, USA, pp. 2–73.
- Weiner D.B., Kern J.A., Schwartz D.A., Nordberg J.E., et al.. (1990) Cancer Res., 50, 5184–5187.
- Whang-Peng J., Kao-Shan C.S., Lee E.C., Bunn P.A., et al.. (1992) Science, 215, 181–182.
- Wistuba I.I., Behrens C., Virmani A.K., Mele G., et al.. (2000) Cancer Res., 60, 1949–1960.
- Yanagisawa K., Kondo M., Osada H., Uchida K., et al.. (1996) Cancer Res., 56, 5579–5582.
- Yang P. (2011) Sem. Resp. Crit. Care M., 32(1), 10–21.
- Yang T.L., Su Y.R., Huang C.S., Yu J.C., et al.. (2004) Gene. Chromosome. Canc., 41(3), 250–256.
- Yarden Y., Sliwkowski M.X. (2001) Nat. Rev. Mol. Cell Biol., 2(2), 127–137.
- Yashima K., Litzky L.A., Kaiser L., Rogers T., et al.. (1997) Cancer Res., 57, 2373–2377.
- Yen C.C., Liang S.C., Jong Y.J., Chen Y.J., et al.. (2007) Lung Cancer, 57(3), 292–301.
- Yuen K.W.Y. (2010) In: eLS, John Wiley & Sons Ltd, Chichester <http://www.els.net>
- Zander D.S., Popper H.H., Jagirdar J., Haque A., Barrios R. (Eds,) (2008) Molecular Pathology of Lung Diseases, Springer, New York.
- Zhang Z. (2010) Study of Molecular Mechanisms, PhD Dissertation, Case Western Reserve University.